Intervention for medication management in kidney transplant recipients

Not Applicable

• Conditions: Kidney transplant recipients; Urological and Genital Diseases

• Registration Number: ISRCTN14528733
• Lead Sponsor: King's College London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-13
• Last Update Posted: 9 September 2024
• Study Completion: 2025-06-06

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Phase 1 inclusion criteria:
1. 18 years of age or over
2. Living with kidney disease
3. Speak and understand English

Phase 2 patient participant inclusion criteria:
1. 18 years of age or over
2. Living with a kidney transplant
3. Prescribed immunosuppression medication.
4. Read and speak English
5. Evidence of sub-optimal immunosuppression medication adherence,i.e. a score of =23 on the Medication Adherence Rating Scale (MARS-5)

Phase 2 healthcare professional participant inclusion criteria:
1. The healthcare professional is a consultant nephrologist, specialist renal transplant nurse, renal pharmacist or renal psychologist working in Guy’s Kidney Clinic.

Exclusion Criteria

Phase 1 exclusion criteria:
1. Currently under the care of a psychiatrist for a mental health condition
2. Insufficient command of English

Phase 2 patient participant exclusion criteria:
1. Currently under the care of a psychiatrist for a mental health condition
2. Evidence of optimal immunosuppression medication adherence on the Medication Adherence Rating Scale (MARS-5), i.e. a total score of 24 or 25
3. Insufficient command of English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility will be assessed by collecting descriptive data on eligibility, recruitment and retention rates. The following will be determined:<br>1. Eligibility rate, recorded as the percentage of patients screened who meet the inclusion criteria<br>2. Uptake, recorded as the percentage of eligible patients agreeing to participate in the study by the end of recruitment<br>3. Retention, recorded as the percentage of participants who remain until the end of the study (i.e. complete the post-intervention questionnaire)